Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Tables)

v3.10.0.1
Segment Information (Tables)
6 Months Ended
Jun. 30, 2018
Segment Reporting [Abstract]  
Schedule of Segment Information

Selected financial information for the Company’s operating segments is as follows:

 

    Three Months Ended June 30,     Six Months Ended June 30,  
    2018     2017     2018     2017  
Net revenues - External                                
Clinical Laboratory Operations   $ 114,736     $ 74,565     $ 160,321     $ 758,830  
Hospital Operations     3,177,481       -       4,733,556       -  
    $ 3,292,217     $ 74,565     $ 4,893,877     $ 758,830  
(Loss) income from operations                                
Clinical Laboratory Operations   $ (462,271 )   $ (1,477,754 )   $ (1,218,354 )   $ (2,770,029 )
Hospital Operations     (1,231,764 )     (553,352 )     (2,704,363 )     (1,020,668 )
Corporate     (699,350 )     (1,884,287 )     (2,182,691 )     (3,688,804 )
Eliminations     -       330       -       8,181  
    $ (2,393,385 )   $ (3,915,063 )   $ (6,105,408 )   $ (7,471,320 )
Depreciation and amortization                                
Clinical Laboratory Operations   $ 217,495     $ 419,905     $ 512,969     $ 854,373  
Corporate     248       349       562       661  
Hospital Operations     99,991       -       137,717       -  
Eliminations     -       (330 )     -       (8,181 )
    $ 317,734     $ 419,924     $ 651,248     $ 846,853  
Capital expenditures                                
Clinical Laboratory Operations   $ -     $ -     $ -     $ -  
Hospital Operations     -       214,147       -       1,394,087  
Eliminations     -       -       -       -  
    $ -     $ 214,147     $ -     $ 1,394,087  

 

    June 30, 2018     December 31, 2017  
Total assets                
Clinical Laboratory Operations   $ 789,278     $ 1,503,520  
Supportive Software Solutions     1,697,042       2,549,504  
Decision Support and Informatics     36,870       -  
Hospital Operations     11,783,059       3,436,773  
Corporate     5,446,170       255,566  
Eliminations     (3,506,174 )     (1,454,569 )
Total Assets   $ 16,246,245     $ 6,290,794